#GoldenCross $MRNS at 12.01 R539 HiLo 91% T1Y 7 strong_buy fwdPE -21.8 DIV N/A #Marinus Ph #stocks #trading #finance #market

2020-09-24
20 Views

Golden Cross detected for MRNS (Marinus Pharmaceutic) at the close price of 12.01. Trading at a 91 % level between the 52week High (13.08) and 52week Low (1.01). The average analyst 1-year target price is 7.0 with an average strong_buy and a score of 0.0.

Golden Cross
539 %
MRNS
12.01
Marinus Pharmaceutic
HiLo
91.1 %
Support
1.88
Resistance
12.01
50DMA
2.22
200DMA
2.21
52week high
13.08
52week low
1.01
10DMA
3.75
20DMA
2.80
100 Mean
2.37
Volume
1214546
AvgDayVol
4823506
MarketCap
1467670016
EBITDA
-62474000
Revenue
0
PE
0.00
P2S
0.00
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

HILO Index 112 Current 91.3 MA20 -12.58 Lower 142.38 Upper Bound #stocks #trading #markets #finance
Global Indicators,
12 views
Global Indicators,
12 views

HILO Index 112 Current 91.3 MA20 -12.58 Lower 142.38 Upper Bound #stocks #trading #markets #finance

Andreas Aigner - 2020-10-20

HILO Index 112 Current 91.3 MA20 -12.58 Lower 142.38 Upper Bound #stocks #trading #markets #finance x

Demark B/S Index -2.15 Avg 26.23 Std 1 Curr #stocks #trading #markets #finance
Global Indicators,
10 views
Global Indicators,
10 views

Demark B/S Index -2.15 Avg 26.23 Std 1 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-10-20

Demark B/S Index -2.15 Avg 26.23 Std 1 Curr #stocks #trading #markets #finance

50/200 DMA Index 1.92 Avg 3.98 Std 1 Curr #stocks #trading #markets #finance
Global Indicators,
12 views
Global Indicators,
12 views

50/200 DMA Index 1.92 Avg 3.98 Std 1 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-10-20

50/200 DMA Index 1.92 Avg 3.98 Std 1 Curr #stocks #trading #markets #finance x

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.